APRE icon

Aprea Therapeutics
APRE

Overview Fund Activity

26 hedge funds and large institutions have $3.78M invested in Aprea Therapeutics in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$61.4K
2
TRCT
2
Tower Research Capital (TRC)
New York
$6.79K
3
BNP Paribas Financial Markets
3
BNP Paribas Financial Markets
France
$28K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$88K
5
Bank of America
5
Bank of America
North Carolina
$9.9K

Top Sellers

1
EAM
1
Exome Asset Management
New York
$59.1K
2
UBS Group
2
UBS Group
Switzerland
$6
3
LCM
3
Landscape Capital Management
New Jersey
$63K
4
Morgan Stanley
4
Morgan Stanley
New York
$66.9K
5
SCM
5
Stonepine Capital Management
Oregon
$14.4K
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
$6 -$11.9K -5,932 -100%
Citigroup
27
Citigroup
New York
– -$79 -24 Closed
1
2